Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Acute Pain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01904149
What this trial is testing

Oral Treatment for Gynaecological Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride

Who this might be right for
Acute Pain
Menarini Group 606
Large-scale testing (Phase 3)Study completedNCT02815709
What this trial is testing

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

Who this might be right for
Acute Pain
Trevena Inc. 418
Large-scale testing (Phase 3)Study completedNCT06423703
What this trial is testing

Cebranopadol for the Treatment of Acute Pain After Bunionectomy

Who this might be right for
Acute Pain
Tris Pharma, Inc. 240
Post-approval studies (Phase 4)Study completedNCT05170841
What this trial is testing

Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain

Who this might be right for
Low Back Pain
Menarini International Operations Luxembourg SA 538
Post-approval studies (Phase 4)Study completedNCT02777970
What this trial is testing

Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar

Who this might be right for
Acute Pain
Menarini Group 654
Post-approval studies (Phase 4)Study completedNCT03798899
What this trial is testing

Efficacy and Safety of Penthrox® Combined With a Standard Analgesia (SoC) in Adult Patients Admitted to the Emergency Department With Moderate to Severe Pain Associated With Trauma

Who this might be right for
Pain, Acute
Mundipharma SAS 360
Testing effectiveness (Phase 2)Study completedNCT04645953
What this trial is testing

Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome

Who this might be right for
Cyclic Vomiting Syndrome
Alexza Pharmaceuticals, Inc. 150
Post-approval studies (Phase 4)Ended earlyNCT00779038
What this trial is testing

Safety and Efficacy Study of Fentanyl Iontophoretic Transdermal System (ITS) for Management of Moderate to Severe Acute Pain in Participants Who Have Undergone Elective Spine or Orthopedic Surgery

Who this might be right for
Pain, Postoperative
Janssen Cilag N.V./S.A. 13
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Post-approval studies (Phase 4)Ended earlyNCT03896230
What this trial is testing

Ketamine for Pain in the Emergency Department

Who this might be right for
Acute Pain
Hackensack Meridian Health 11
Testing effectiveness (Phase 2)Looking for participantsNCT06394830
What this trial is testing

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

Who this might be right for
Interstitial CystitisBladder Pain Syndrome
Vaneltix Pharma, Inc. 50
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Large-scale testing (Phase 3)WithdrawnNCT01324544
What this trial is testing

Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain

Who this might be right for
Other Acute Postoperative PainProlonged Endotracheal Intubation
Purdue Pharma LP
Large-scale testing (Phase 3)Study completedNCT00943098
What this trial is testing

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery

Who this might be right for
Dental Pain
IBSA Institut Biochimique SA 142
Post-approval studies (Phase 4)Looking for participantsNCT06320041
What this trial is testing

Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery

Who this might be right for
Postoperative Pain
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 162
Large-scale testing (Phase 3)Study completedNCT02820324
What this trial is testing

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty

Who this might be right for
Acute Pain
Trevena Inc. 407
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Post-approval studies (Phase 4)Ended earlyNCT02746263
What this trial is testing

Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain

Who this might be right for
Acute Pain, Postoperative
Mallinckrodt 1
Post-approval studies (Phase 4)Ended earlyNCT03959852
What this trial is testing

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Who this might be right for
Pain, Acute
Mercy Health Ohio 6
Testing effectiveness (Phase 2)Looking for participantsNCT07511816
What this trial is testing

LY4515100 in Participants With Pain Following Third Molar Removal

Who this might be right for
Acute PainMolarMolar, Third+1 more
Eli Lilly and Company 212
Next Page